Genetics Generation Advancement Balance Sheet Health
Financial Health criteria checks 5/6
Genetics Generation Advancement has a total shareholder equity of NT$430.1M and total debt of NT$30.0M, which brings its debt-to-equity ratio to 7%. Its total assets and total liabilities are NT$595.1M and NT$164.9M respectively. Genetics Generation Advancement's EBIT is NT$18.6M making its interest coverage ratio -3.9. It has cash and short-term investments of NT$314.2M.
Key information
7.0%
Debt to equity ratio
NT$30.00m
Debt
Interest coverage ratio | -3.9x |
Cash | NT$314.21m |
Equity | NT$430.15m |
Total liabilities | NT$164.91m |
Total assets | NT$595.05m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 4160's short term assets (NT$456.6M) exceed its short term liabilities (NT$154.6M).
Long Term Liabilities: 4160's short term assets (NT$456.6M) exceed its long term liabilities (NT$10.3M).
Debt to Equity History and Analysis
Debt Level: 4160 has more cash than its total debt.
Reducing Debt: 4160's debt to equity ratio has increased from 0% to 7% over the past 5 years.
Debt Coverage: 4160's debt is well covered by operating cash flow (222.9%).
Interest Coverage: 4160 earns more interest than it pays, so coverage of interest payments is not a concern.